Indegene Ltd.

₹600.1

Indegene Ltd.

₹600.1

₹600.1

-5.85 (-0.97%) - 24 May 2025 03:33 PM

About Company

Indegene provides digital-led commercialization services for the life sciences industry, including biopharmaceutical, emerging biotech and medical devices companies, that assist them with drug development and clinical trials, regulatory submissions, pharmacovigilance and complaints management, and the sales and marketing of their products. Its solutions enable life sciences companies to develop products, launch them in the market, and drive sales through their life cycle in a more effective, efficient and modern manner. It achieves this by combining over two decades of healthcare domain expertise and fit-for purpose technology. 

Market Cap. ₹ 14,406 Cr.
52 Week - High/Low ₹ 736/470
P/E Ratio 79.17
P/B Ratio 15.10
Enterprise Value ₹ 38 Cr.
ROE % 16.22
RSI Value 59.15
EMA 50 573.03
EMA 200 587.96
Market Cap. ₹ 14,406 Cr.
52 Week - High/Low ₹ 736/470
P/E Ratio 35.30
P/B Ratio 10.08
Enterprise Value ₹ 244 Cr.
ROE % 27.56
RSI Value 59.15
EMA 50 573.03
EMA 200 587.96

Growth

Valuation

Calculators

Peer Comparison

Industry - Pharmaceuticals & Drugs

* Please refer to the Standalone data if Consolidated financial data for the company is not available.

Shareholding Pattern Numbers in percentages

Insight market
Copyright © 2025 All rights reserved with INVESMATE INSIGHTS PRIVATE LIMITED | All logos and Trademarks registered with their respective owners.